231 related articles for article (PubMed ID: 26769750)
1. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
Hayashi T; Gust KM; Wyatt AW; Goriki A; Jäger W; Awrey S; Li N; Oo HZ; Altamirano-Dimas M; Buttyan R; Fazli L; Matsubara A; Black PC
Clin Cancer Res; 2016 Jun; 22(12):2981-92. PubMed ID: 26769750
[TBL] [Abstract][Full Text] [Related]
2. Unravelling disparate roles of NOTCH in bladder cancer.
Goriki A; Seiler R; Wyatt AW; Contreras-Sanz A; Bhat A; Matsubara A; Hayashi T; Black PC
Nat Rev Urol; 2018 Jun; 15(6):345-357. PubMed ID: 29643502
[TBL] [Abstract][Full Text] [Related]
3. NOTCH pathway inactivation promotes bladder cancer progression.
Maraver A; Fernandez-Marcos PJ; Cash TP; Mendez-Pertuz M; Dueñas M; Maietta P; Martinelli P; Muñoz-Martin M; Martínez-Fernández M; Cañamero M; Roncador G; Martinez-Torrecuadrada JL; Grivas D; de la Pompa JL; Valencia A; Paramio JM; Real FX; Serrano M
J Clin Invest; 2015 Feb; 125(2):824-30. PubMed ID: 25574842
[TBL] [Abstract][Full Text] [Related]
4. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
Wang K; Zhang Q; Li D; Ching K; Zhang C; Zheng X; Ozeck M; Shi S; Li X; Wang H; Rejto P; Christensen J; Olson P
Clin Cancer Res; 2015 Mar; 21(6):1487-96. PubMed ID: 25564152
[TBL] [Abstract][Full Text] [Related]
5. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
[TBL] [Abstract][Full Text] [Related]
6. NOTCH2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma.
Zou Y; Yang R; Huang ML; Kong YG; Sheng JF; Tao ZZ; Gao L; Chen SM
J Exp Clin Cancer Res; 2019 Nov; 38(1):456. PubMed ID: 31699119
[TBL] [Abstract][Full Text] [Related]
7. CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.
Zhou Z; Cui D; Sun MH; Huang JL; Deng Z; Han BM; Sun XW; Xia SJ; Sun F; Shi F
FASEB J; 2020 Jun; 34(6):7970-7988. PubMed ID: 32293074
[TBL] [Abstract][Full Text] [Related]
8. Pathobiology of Notch2 in lung cancer.
Motooka Y; Fujino K; Sato Y; Kudoh S; Suzuki M; Ito T
Pathology; 2017 Aug; 49(5):486-493. PubMed ID: 28666642
[TBL] [Abstract][Full Text] [Related]
9. Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis.
Gifford GB; Demitrack ES; Keeley TM; Tam A; La Cunza N; Dedhia PH; Spence JR; Simeone DM; Saotome I; Louvi A; Siebel CW; Samuelson LC
Gut; 2017 Jun; 66(6):1001-1011. PubMed ID: 26933171
[TBL] [Abstract][Full Text] [Related]
10. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model.
Baumgart A; Mazur PK; Anton M; Rudelius M; Schwamborn K; Feuchtinger A; Behnke K; Walch A; Braren R; Peschel C; Duyster J; Siveke JT; Dechow T
Oncogene; 2015 Jan; 34(5):578-88. PubMed ID: 24509876
[TBL] [Abstract][Full Text] [Related]
11. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
Yen WC; Fischer MM; Axelrod F; Bond C; Cain J; Cancilla B; Henner WR; Meisner R; Sato A; Shah J; Tang T; Wallace B; Wang M; Zhang C; Kapoun AM; Lewicki J; Gurney A; Hoey T
Clin Cancer Res; 2015 May; 21(9):2084-95. PubMed ID: 25934888
[TBL] [Abstract][Full Text] [Related]
12. The different role of Notch1 and Notch2 in astrocytic gliomas.
Xu P; Zhang A; Jiang R; Qiu M; Kang C; Jia Z; Wang G; Han L; Fan X; Pu P
PLoS One; 2013; 8(1):e53654. PubMed ID: 23349727
[TBL] [Abstract][Full Text] [Related]
13. Effect of notch1,2,3 genes silicing on NF-κB signaling pathway of macrophages in patients with atherosclerosis.
Ruan ZB; Fu XL; Li W; Ye J; Wang RZ; Zhu L
Biomed Pharmacother; 2016 Dec; 84():666-673. PubMed ID: 27697639
[TBL] [Abstract][Full Text] [Related]
14. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
15. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
16. NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells.
Okuhashi Y; Itoh M; Nara N; Tohda S
Anticancer Res; 2013 Oct; 33(10):4293-8. PubMed ID: 24122995
[TBL] [Abstract][Full Text] [Related]
17. Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines.
Hassan WA; Yoshida R; Kudoh S; Hasegawa K; Niimori-Kita K; Ito T
Lung Cancer; 2014 Dec; 86(3):304-10. PubMed ID: 25456735
[TBL] [Abstract][Full Text] [Related]
18. Notch2 signaling contributes to cell growth, invasion, and migration in salivary adenoid cystic carcinoma.
Qu J; Song M; Xie J; Huang XY; Hu XM; Gan RH; Zhao Y; Lin LS; Chen J; Lin X; Zheng DL; Lu YG
Mol Cell Biochem; 2016 Jan; 411(1-2):135-41. PubMed ID: 26427670
[TBL] [Abstract][Full Text] [Related]
19. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
20. NOTCH1 and NOTCH2 regulate epithelial cell proliferation in mouse and human gastric corpus.
Demitrack ES; Gifford GB; Keeley TM; Horita N; Todisco A; Turgeon DK; Siebel CW; Samuelson LC
Am J Physiol Gastrointest Liver Physiol; 2017 Feb; 312(2):G133-G144. PubMed ID: 27932500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
